Main Area

ExCellThera’s Safer Allogeneic Transplants

Posted on December 14th, 2018

How ExCellThera is increasing the safety of allogeneic stem cell transplants

ExCellThera Inc. is expanding cord blood into allogeneic stem cell transplants for cancer that have lower treatment-related mortality rates and GvHD incidence than competing technologies. Hematopoietic stem cell transplants (HSCTs) of unexpanded cord blood have two key drawbacks, according to CFO and Chief Legal Officer David Millette… BioCentury, December 14, 2019 (paywalled)